Patents by Inventor Per-Goran Gillberg

Per-Goran Gillberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IBAT inhibitors for the treatment of liver diseases
    Patent number: 9688720
    Abstract: The present invention regards specific IBAT inhibitors useful in the prophylaxis and/or treatment of a liver disease. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: June 27, 2017
    Assignee: Albireo AB
    Inventors: Per-Göran Gillberg, Hans Graffner, Ingemar Starke
  • IBAT INHIBITORS FOR THE TREATMENT OF LIVER DISEASES
    Publication number: 20160193277
    Abstract: The present invention regards specific IBAT inhibitors useful in the prophylaxis and/or treatment of a liver disease. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.
    Type: Application
    Filed: March 14, 2016
    Publication date: July 7, 2016
    Inventors: Per-Göran Gillberg, Hans Graffner, Ingemar Starke
  • IBAT INHIBITORS FOR THE TREATMENT OF LIVER DISEASES
    Publication number: 20160194353
    Abstract: The present invention regards specific IBAT inhibitors useful in the prophylaxis and/or treatment of a liver disease. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.
    Type: Application
    Filed: March 14, 2016
    Publication date: July 7, 2016
    Inventors: Per-Göran Gillberg, Hans Graffner, Ingemar Starke
  • PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER
    Publication number: 20150031637
    Abstract: The present invention relates to a combination comprising a substance with inhibiting effect on the ileal bile acid transport system (IBAT) and at least one other active substance selected from an IBAT inhibitor; an enteroendocrine peptide or enhancer thereof; a dipeptidyl peptidase-IV inhibitor; a biguanidine; an incretin mimetic; a thiazolidinone; a PPAR agonist; a HMG Co-A reductase inhibitor; a bile acid binder; and a TGR5 receptor modulator; wherein the IBAT inhibitor compound and the at least one other active substance are administered simultaneously, sequentially or separately.
    Type: Application
    Filed: October 3, 2014
    Publication date: January 29, 2015
    Inventors: Per-Göran Gillberg, Hans Graffner, Ingemar Starke
  • IBAT INHIBITORS FOR THE TREATMENT OF LIVER DISEASES
    Publication number: 20150031636
    Abstract: The present invention regards specific IBAT inhibitors useful in the prophylaxis and/or treatment of a liver disease. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.
    Type: Application
    Filed: October 3, 2014
    Publication date: January 29, 2015
    Inventors: Per-Göran Gillberg, Hans Graffner, Ingemar Starke
  • PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER
    Publication number: 20130236541
    Abstract: The present invention relates to a combination comprising a substance with inhibiting effect on the ileal bile acid transport system (I BAT) and at least one other active substance selected from an IBAT inhibitor; an enteroendocrine peptide or enhancer thereof; a dipeptidyl peptidase-IV inhibitor; a biguanidine; an incretin mimetic; a thiazolidinone; a PPAR agonist; a HMG Co-A reductase inhibitor; a bile acid binder; and a TGR5 receptor modulator; wherein the IBAT inhibitor compound and the at least one other active substance are administered simultaneously, sequentially or separately.
    Type: Application
    Filed: November 8, 2011
    Publication date: September 12, 2013
    Applicant: Albireo AB
    Inventors: Per-Göran Gillberg, Hans Graffner, Ingemar Starke
  • IBAT INHIBITORS FOR THE TREATMENT OF LIVER DISEASES
    Publication number: 20130225511
    Abstract: The present invention regards specific IBAT inhibitors useful in the prophylaxis and/or treatment of a liver disease. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.
    Type: Application
    Filed: November 8, 2011
    Publication date: August 29, 2013
    Inventors: Per-Göran Gillberg, Hans Graffner, Ingemar Starke
  • IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS
    Publication number: 20120114588
    Abstract: The present invention regards specific IBAT inhibitors with improved effect in prophylaxis and treatment of metabolic syndrome, obesity, disorders of fatty acid metabolism, glucose utilization disorders, disorders in which insulin resistance is involved, diabetes mellitus, type 1 and type 2 diabetes. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.
    Type: Application
    Filed: May 26, 2011
    Publication date: May 10, 2012
    Applicant: ALBIREO AB
    Inventors: Ingemar Starke, Hans Graffner, Per-Göran Gillberg, Ann-Margret Lindqvist, Bo Angelin
  • Use of an IBAT inhibitor for the treatment of constipation
    Patent number: 7514421
    Abstract: A method of treatment of functional constipation or C-IBS in a warm-blooded animal is disclosed, which comprises the administration of an IBAT inhibitor.
    Type: Grant
    Filed: April 1, 2004
    Date of Patent: April 7, 2009
    Assignee: Albireo AB
    Inventors: Hasse Roland Abrahamsson, Per-Goran Gillberg
  • Use of an ibat inhibitor for the treatment of prophylaxis of constipation
    Publication number: 20060199797
    Abstract: The use of an IBAT inhibitor in the treatment and/or prophylaxis of constipation, in a warm-blooded animal, such as man is described.
    Type: Application
    Filed: April 1, 2004
    Publication date: September 7, 2006
    Inventors: Hasse Abrahamsson, Per-Goran Gillberg
  • Use of tolterodine to treat asthma
    Patent number: 6538035
    Abstract: The present invention is a method of treating an mammal selected from the group consisting of humans and horses who has asthma, COPD or allergic rhinitis and is in need of such treatment by inhaling an anti-asthma, anti-COPD anti-allergic rhinitis effective amount, respectively, of a compound selected from the group consisting of tolterodine hydroxytolterodine and 2-(diisopropylamino)ethyl-1-phenylcyclopentanecarboxylate and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: October 23, 2001
    Date of Patent: March 25, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Per-Goran Gillberg, Staffan Sundquist, Sue K. Cammarata
  • Use of tolterodine to treat asthma
    Publication number: 20020161054
    Abstract: The present invention is a method of treating an mammal selected from the group consisting of humans and horses who has asthma, COPD or allergic rhinitis and is in need of such treatment by inhaling an anti-asthma, anti-COPD anti-allergic rhinitis effective amount, respectively, of a compound selected from the group consisting of tolterodine 1
    Type: Application
    Filed: October 23, 2001
    Publication date: October 31, 2002
    Inventors: Per-Goran Gillberg, Staffan Sundquist, Sue K. Cammarata